Why Synergy Pharmaceuticals, Tesla, Tencent and More Are Trending
The markets are in the red again on Friday as all three major indexes are down by over 1%.
Posts Tagged ‘Synergy Pharmaceuticals Inc. (SGYP)’
13G Filing: Paulson & Co and Synergy Pharmaceuticals Inc. (SGYP)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent...
15 Penny Stocks Poised To Explode According To Hedge Funds
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that trades under $5 per share...
Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Price For Synergy Pharmaceuticals Inc (SGYP) Public Offering Announced
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has revealed that the price of its common stock through its upcoming public offering will be $6.15 a share.
FDA Approves Trulance From Synergy Pharmaceuticals Inc (SGYP) To Battle With Allergan PLC (AGN) Linzess
The chronic idiopathic constipation (CIC) market has a new entrant. This was occasioned by the FDA’s approval of Trulance from Synergy Pharmaceuticals Inc (NASDAQ:SGYP).
Synergy Pharmaceuticals Inc (SGYP): A Top January Pick Ahead Of PDUFA
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has gradually picked up strength over the last six months or so, as the company creeps towards its PDUFA date for Plecanatide.
Synergy Pharmaceuticals Inc (SGYP) Moves Closer To Expanding Plecanatide Label
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has provided an update on topline results from a Phase 3 study of its candidate plecanatide.
Synergy Pharmaceuticals Inc (SGYP) Stock Heading Upward On Data Release
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is having a relatively strong day in the market today, and for good reason.
Biotech Movers: Elite Pharmaceuticals Inc (ELTP) and Synergy Pharmaceuticals Inc (SGYP)
Two biotech companies had a rough end to the week last week, and it looks as though things aren’t going to get much better for them heading into the US open on Monday.
10 Battered Biotech Stocks That Hit 52-Week Lows Friday
The markets have been strong over the past two weeks, bucking expectations that Britain's exit from the European Union would lead to a medium-term malaise in the market.
Why These 5 Stocks Are Moving On High Volume Today
After opening in the green, the three major indexes are close to flat today, as volatility remains low.
Hedge Funds’ Favorite Stocks That Have RSI’s Under 30
Retail investors and larger-scale investors such as hedge funds are constantly on the lookout for cheap and oversold stocks that are expected to see fresh buying coming in.
Surging Stocks: Aehr Test Systems, Synergy Pharmaceuticals, Great Basin Scientific, More
All three indexes are in the green on this Tuesday afternoon, as traders are eagerly anticipating Thursday's jobless claims and next week's FOMC meeting.
Most Popular Healthcare Stocks Under $5
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors usually avoiding these low...
Five Cheap Healthcare Stocks With Hedge Fund Support
When it comes to the risk-reward ratio, there are very few sectors which can match up to healthcare.
Five Cheap Healthcare Stocks Poised to Explode
Over the past few months the healthcare sector has undergone a roller coaster of a ride, especially in August and September when many investors got wary of the sector being overvalued...
Elite Hedge Funds Make Big Moves In These 3 Healthcare Stocks
A Schedule 13G is a public filing that must be submitted with the SEC by every hedge fund manager or other investor who acquires ownership of more than 5% in a publicly-traded...
Trellus Management’s Top Biotech Stock Picks For Q4
Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994.
5 Healthcare Stocks Under $10 Ready To Pop
Investing in the healthcare sector can be tricky, especially if you're looking for high returns and want to invest in clinical-stage companies, which represent an above-average...
Hedge Funds Were Right About Synergy Pharmaceuticals Inc (SGYP), Shares Soaring By The Minute, Up 65% Today
Shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) are soaring by the minute today, currently up by 65% following the release of positive data from the biopharmaceutical company...
Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E.
Here is What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)
If you were to ask many market players, hedge funds are seen as useless, outdated financial vehicles of a forgotten age.
Depomed Inc (DEPO): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
In the eyes of many market players, hedge funds are viewed as delayed, outdated financial vehicles of an era lost to time.
Should You Avoid Orexigen Therapeutics, Inc. (OREX)?
In the financial world, there are a multitude of metrics shareholders can use to watch their holdings.
Hedge Funds Are Crazy About Dynavax Technologies Corporation (DVAX)
To the average investor, there are dozens of gauges shareholders can use to track publicly traded companies.
Depomed Inc (DEPO): Hedge Funds and Insiders Are Bullish, What Should You Do?
Depomed Inc (NASDAQ:DEPO) was in 13 hedge funds' portfolio at the end of the first quarter of 2013.
Orexigen Therapeutics, Inc. (OREX): Are Hedge Funds Right About This Stock?
To the average investor, there are plenty of methods shareholders can use to monitor their holdings. A pair of the most useful are hedge fund and insider trading interest.
Insiders Have Bought Bank of America Corp (BAC), JPMorgan Chase & Co. (JPM), and More
Studies show that stocks bought by insiders tend to narrowly outperform broader market indices (read our analysis of studies on insider trading).
ACADIA Pharmaceuticals Inc. (ACAD), Astex Pharmaceuticals, Inc. (ASTX), Pfizer Inc. (PFE), and More: This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Synergy Pharmaceuticals Inc (SGYP) Targets Root Cause Of Irritable Bowel Syndrome
Irritable bowel syndrome has no organic cause and treating it usually depends on reducing symptoms of chronic abdominal pain, bloating, and gastric discomfort.
Big Growth Stories in Biotech: Trius Therapeutics, Inc. (TSRX), Synergy Pharmaceuticals Inc (SGYP)
Bacteria are pure survivalists, and over billions of years they have evolved to produce ever-newer chemicals to protect themselves against other bugs, and in the last 100 years...
